Evidence map›Paper›PMID 40907688›Full record

ArticleEuropean journal of pharmacology2025

Deep learning-driven proteomics analysis for gene annotation in the renin-angiotensin system.

Mortaza Eivazi, Kamran Hosseini, Shahin Alipanahi, Huijing Xia, Luke Restivo, Ayushi Patel, Mahdieh Gozali, Tahereh Ebrahimi, Amy Scarborough, Vahideh Tarhriz and 1 more

Abstract read
In one paragraph

Article in European journal of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mortaza EivaziDepartment of Computer Science, Faculty of Mathematics, Statistics, and Computer Science, University of Tabriz, Tabriz, Iran.
Kamran HosseiniShiraz Neuroscience Research Center (SNRC), Shiraz University of Medical Sciences, Shiraz, Iran.
Shahin AlipanahiDepartment of Computer Science, Faculty of Mathematics, Statistics, and Computer Science, University of Tabriz, Tabriz, Iran.
Huijing XiaCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA; Department of Pharmacology & Experimental Therapeutics, New Orleans, LA, 70112, USA.
Luke RestivoCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Ayushi PatelCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA; Department of Pharmacology & Experimental Therapeutics, New Orleans, LA, 70112, USA.
Mahdieh GozaliMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tahereh EbrahimiMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amy ScarboroughCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Vahideh TarhrizCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA; Southeast Louisiana Veterans Health Care System, New Orleans, LA, 70119, USA. Electronic address: vtarhr@lsuhsc.edu.
Eric LazartiguesCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA; Department of Pharmacology & Experimental Therapeutics, New Orleans, LA, 70112, USA; Southeast Louisiana Veterans Health Care System, New Orleans, LA, 70119, USA. Electronic address: elazar@lsuhsc.edu.

Funding

Targeting ACE2 ubiquitination for hypertensionR01HL150592 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LAZARTIGUES, ERIC D · 2020 to 2023
$2.4M
Targeting ADAM17 maturation in resistant hypertension.R01HL163588 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LAZARTIGUES, ERIC D · 2022 to 2025
$2.2M
BLRD VA I01 BX004294BLRD VA I01 BX005475BLRD VA IK6 BX007112NHLBI NIH HHS R01 HL150592NHLBI NIH HHS R01 HL163588
6 · The paper itself

Abstract

The renin-angiotensin system (RAS) is central to cardiovascular diseases such as hypertension and cardiomyopathy, yet the functions of many RAS genes remain unclear. This study developed a multi-label deep learning model to systematically annotate RAS gene functions and elucidate their roles in biological pathways. A total of 39,463 RAS-related publications from PubMed and PMC were processed into text format. Feature matrices were generated using TF-IDF and token processing, followed by dimensionality reduction via Principal Component Analysis (PCA). A Multi-Layer Perceptron (MLP) was applied for multi-label classification, with performance evaluated using Precision, F1-Score, Ranking Loss, and ROC-AUC metrics. The model outperformed traditional methods (SVM, Random Forest), achieving a Precision of 0.7474 and ROC-AUC of 0.8697. Grouping into three major biological branches improved interpretability and performance (Precision: 0.8312; ROC-AUC: 0.9182). In silico predictions were validated using extracellular vesicle (EV) proteomics and capillary Western assays in DOCA-salt hypertensive mice. Key genes-AGTR2, IRAP (LNPEP), Ywhas (SFN), EDNRA, and ESR2-were identified as critical RAS components. Notably, IRAP was markedly upregulated in hypertension and showed regulatory interactions with 14-3-3 proteins, modulating Nedd4-2, ACE2, and AGTR1 signaling. To our knowledge, this is the first integration of multi-label AI modeling with EV proteomics for RAS pathway annotation. This framework captures complex gene-pathway relationships, advancing systems-level understanding of RAS biology and revealing a novel IRAP/Ywha(s)/Nedd4-2-ACE2 interaction axis as a potential therapeutic target.

Indexed as

Deep LearningMolecular Sequence AnnotationProteomicsRenin-Angiotensin SystemAnimalsHumansHypertensionMiceHypertensionMachine learningMulti-layer perceptronRenin-angiotensin system

Identifiers

PMID40907688
PMCPMC12874735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.